Bot AI - Search Results

1

TLR-9 signaling and TCR stimulation co-regulate CD8(+) T cell-associated PD-1 expression.

Wong RM, Smith KA, Tam VL, Pagarigan RR, Meisenburg BL, Quach AM, Carrillo MA, Qiu Z, Bot AI. Wong RM, et al. Among authors: bot ai. Immunol Lett. 2009 Dec 2;127(1):60-7. doi: 10.1016/j.imlet.2009.09.002. Epub 2009 Sep 12. Immunol Lett. 2009. PMID: 19751765

2

Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccination.

Smith KA, Qiu Z, Wong R, Tam VL, Tam BL, Joea DK, Quach A, Liu X, Pold M, Malyankar UM, Bot A. Smith KA, et al. Cancer Gene Ther. 2011 Jan;18(1):63-76. doi: 10.1038/cgt.2010.45. Epub 2010 Aug 20. Cancer Gene Ther. 2011. PMID: 20725097

3

Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity.

Bot A, Qiu Z, Wong R, Obrocea M, Smith KA. Bot A, et al. J Transl Med. 2010 Dec 14;8:132. doi: 10.1186/1479-5876-8-132. J Transl Med. 2010. PMID: 21144062 Free PMC article.

4

Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides.

Smith KA, Tam VL, Wong RM, Pagarigan RR, Meisenburg BL, Joea DK, Liu X, Sanders C, Diamond D, Kündig TM, Qiu Z, Bot A. Smith KA, et al. Vaccine. 2009 Apr 28;27(19):2603-15. doi: 10.1016/j.vaccine.2009.02.038. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19428867

5

Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors.

Smith KA, Meisenburg BL, Tam VL, Pagarigan RR, Wong R, Joea DK, Lantzy L, Carrillo MA, Gross TM, Malyankar UM, Chiang CS, Da Silva DM, Kündig TM, Kast WM, Qiu Z, Bot A. Smith KA, et al. Clin Cancer Res. 2009 Oct 1;15(19):6167-76. doi: 10.1158/1078-0432.CCR-09-0645. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789304 Free PMC article.

6

Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology.

Bot A, Smith KA, von Herrath M. Bot A, et al. DNA Cell Biol. 2004 Jun;23(6):341-50. doi: 10.1089/104454904323145227. DNA Cell Biol. 2004. PMID: 15231067 Review.

7

Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration.

von Beust BR, Johansen P, Smith KA, Bot A, Storni T, Kündig TM. von Beust BR, et al. Eur J Immunol. 2005 Jun;35(6):1869-76. doi: 10.1002/eji.200526124. Eur J Immunol. 2005. PMID: 15909311 Free article.

8

International reviews of immunology: expanding the scope and content.

Bot A, Smith K. Bot A, et al. Int Rev Immunol. 2008;27(4):177-82. doi: 10.1080/08830180802148378. Int Rev Immunol. 2008. PMID: 18574735 No abstract available.

9

Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions.

Bot A, Marincola F, Smith KA. Bot A, et al. Expert Rev Vaccines. 2013 Oct;12(10):1219-34. doi: 10.1586/14760584.2013.836908. Epub 2013 Oct 8. Expert Rev Vaccines. 2013. PMID: 24099049 Review.

10

Phase 1 trial of intranodal injection of a Melan-A/MART-1 DNA plasmid vaccine in patients with stage IV melanoma.

Weber J, Boswell W, Smith J, Hersh E, Snively J, Diaz M, Miles S, Liu X, Obrocea M, Qiu Z, Bot A. Weber J, et al. J Immunother. 2008 Feb-Mar;31(2):215-23. doi: 10.1097/CJI.0b013e3181611420. J Immunother. 2008. PMID: 18481391 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters